Abiopharma

New Form 8-K - Cidara Therapeutics, Inc. Filed: 2025-06-25 AccNo: 0001193125-25-147011 Size: 471 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 4 - UNITED THERAPEUTICS Corp Filed: 2025-06-25 AccNo: 0001562180-25-005066 Size: 5 KB

New Form SCHEDULE 13G - Aptevo Therapeutics Inc. Filed: 2025-06-25 AccNo: 0001213900-25-057838 Size: 21 KB

New Form 4 - Nautilus Biotechnology, Inc. Filed: 2025-06-25 AccNo: 0001808805-25-000063 Size: 5 KB

New Form 4 - Nautilus Biotechnology, Inc. Filed: 2025-06-25 AccNo: 0001808805-25-000064 Size: 5 KB

New Form 4 - Nautilus Biotechnology, Inc. Filed: 2025-06-25 AccNo: 0001808805-25-000061 Size: 5 KB

New Form 4 - Nautilus Biotechnology, Inc. Filed: 2025-06-25 AccNo: 0001808805-25-000062 Size: 5 KB

New Form 4 - Nautilus Biotechnology, Inc. Filed: 2025-06-25 AccNo: 0001808805-25-000060 Size: 5 KB

New Form 4 - UNITED THERAPEUTICS Corp Filed: 2025-06-25 AccNo: 0001562180-25-005065 Size: 8 KB

New Form 424B5 - Cidara Therapeutics, Inc. Filed: 2025-06-25 AccNo: 0001193125-25-147004 Size: 708 KB

New Form 8-K - Annexon, Inc. Filed: 2025-06-25 AccNo: 0001193125-25-147005 Size: 156 KB Item 3.03: Material Modifications to Rights of Security Holders Item 9.01: Financial Statements and Exhibits

New Form 144 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed: 2025-06-25 AccNo: 0001964306-25-000269 Size: 4 KB

New Form SCHEDULE 13D/A - ENZO BIOCHEM INC Filed: 2025-06-25 AccNo: 0000921895-25-001834 Size: 12 KB

New Form 8-K - DBV Technologies S.A. Filed: 2025-06-25 AccNo: 0001193125-25-146994 Size: 234 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Tivic Health Systems, Inc. Filed: 2025-06-25 AccNo: 0000950170-25-089981 Size: 527 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits